These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31011676)

  • 41. Response assessment after stereotactic body radiation therapy for spine and non-spine bone metastases: results from a single institutional study.
    Correia D; Moullet B; Cullmann J; Heiss R; Ermiş E; Aebersold DM; Hemmatazad H
    Radiat Oncol; 2022 Feb; 17(1):37. PubMed ID: 35189919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy.
    Scheenstra AE; Rossi MM; Belderbos JS; Damen EM; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):224-8. PubMed ID: 24331668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".
    Hoerner-Rieber J; Duma M; Blanck O; Hildebrandt G; Wittig A; Lohaus F; Flentje M; Mantel F; Krempien R; Eble MJ; Kahl KH; Boda-Heggemann J; Rieken S; Guckenberger M
    J Thorac Dis; 2017 Nov; 9(11):4512-4522. PubMed ID: 29268521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
    Ma SJ; Serra LM; Syed YA; Hermann GM; Gomez-Suescun JA; Singh AK
    Clin Lung Cancer; 2018 Mar; 19(2):e235-e240. PubMed ID: 29153897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
    Guckenberger M; Mantel F; Sweeney RA; Hawkins M; Belderbos J; Ahmed M; Andratschke N; Madani I; Flentje M
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):348-357. PubMed ID: 33412262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer.
    Phak JH; Kim HJ; Kim WC
    Prostate Int; 2016 Mar; 4(1):25-9. PubMed ID: 27014661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.
    Avkshtol V; Dong Y; Hayes SB; Hallman MA; Price RA; Sobczak ML; Horwitz EM; Zaorsky NG
    Res Rep Urol; 2016; 8():145-58. PubMed ID: 27574585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence.
    Decaestecker K; De Meerleer G; Lambert B; Delrue L; Fonteyne V; Claeys T; De Vos F; Huysse W; Hautekiet A; Maes G; Ost P
    Radiat Oncol; 2014 Jun; 9():135. PubMed ID: 24920079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
    Stinauer MA; Kavanagh BD; Schefter TE; Gonzalez R; Flaig T; Lewis K; Robinson W; Chidel M; Glode M; Raben D
    Radiat Oncol; 2011 Apr; 6():34. PubMed ID: 21477295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer.
    Lee SH; Kim HJ; Kim WC
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):388-395. PubMed ID: 27461444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer.
    Gogineni E; Rana Z; Soberman D; Sidiqi B; D'Andrea V; Lee L; Potters L; Parashar B
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1232-1242. PubMed ID: 33171199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?
    Woo JA; Chen LN; Wang H; Cyr RA; Bhattasali O; Kim JS; Moures R; Yung TM; Lei S; Collins BT; Suy S; Dritschilo A; Lynch JH; Collins SP
    Front Oncol; 2015; 5():77. PubMed ID: 25874188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer.
    Moningi S; Lei X; Fang P; Taniguchi CM; Holliday EB; Koay EJ; Koong AC; Ludmir EB; Minsky BD; Das P; Giordano SH; Smith GL
    Clin Transl Radiat Oncol; 2022 Jul; 35():9-16. PubMed ID: 35510142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study.
    Sanguineti G; Arcidiacono F; Landoni V; Saracino BM; Farneti A; Arcangeli S; Petrongari MG; Gomellini S; Strigari L; Arcangeli G
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):304-312. PubMed ID: 27475670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy.
    Torok J; Wegner RE; Burton SA; Heron DE
    Future Oncol; 2011 Jan; 7(1):145-51. PubMed ID: 21174545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer.
    Oliai C; Bernetich M; Brady L; Yang J; Hanlon A; Lamond J; Arrigo S; Good M; Mooreville M; Garber B; Lanciano R
    J Radiat Oncol; 2016; 5():187-195. PubMed ID: 27335630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer.
    Sood S; Ju AW; Wang H; Lei S; Uhm S; Zhang G; Suy S; Carroll J; Lynch J; Dritschilo A; Collins SP
    Radiat Oncol; 2013 Aug; 8():197. PubMed ID: 23937800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
    Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.